Discrete Choice Experiment to Estimate Breast Cancer Patients' Preferences and Willingness to Pay for Prophylactic Granulocyte Colony-Stimulating Factors

Participants highly valued specific features of prophylactic G-CSF treatment including maintaining their chemotherapy schedule, lowering their risk of infection, and reducing the number of injections. Physicians should consider patient preferences to inform the best treatment choices for individual patients.